Thermo Fisher Scientific and CSL enter strategic partnershipChristian Fernsby ▼ | May 27, 2020
Thermo Fisher Scientific and CSL announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies.
CSL Thermo Fisher will support CSL's product portfolio
Topics: Thermo Fisher Scientific
Through a long term lease agreement with CSL, Thermo Fisher will operate a new state of the art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in mid 2021.
Within the Lengnau site, Thermo Fisher will support manufacturing of CSL's next-generation product for hemophilia patients. The site will feature highly flexible bioproduction technologies, including single-use and stainless steel, to provide a pathway from development to large-scale production as customers' needs increase. Over time, Thermo Fisher plans to expand the use of the site to include additional biopharma customers. ■